Trial Profile
An open label study of tocilizumab in patients with polymyalgia rheumatica
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Feb 2016
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary) ; Prednisone
- Indications Polymyalgia rheumatica
- Focus Therapeutic Use
- 02 Feb 2016 New trial record